ABIO: Arca Biopharma, Inc. Instablogs

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 30, 12:44 PM Midday top 10 gainers: NBG +475%. CLWR +24%. NVE +22%. GV +19%. AIQ +17%. BVX +16%. CLSN +16%. AAU +15%. BAA +14%. GURE +13%.
Midday top 10 Losers: ABIO -30%. VIMC -20%. DLIA -13%. VRTB -11%. CVI -11%. HSOL -10%. WPCS -10%. AGII -9%. ARTX -8%. ALVR -8%. 5 Comments [On the Move]
Thursday, May 30, 9:29 AM Arca Biopharma (ABIO) plunges 30% premarket after announcing the pricing of a $20M equity offering. The company will issue ~125K preferred shares ($160/share, convertible to 100 shares of common, come with a warrant to purchase 50 shares of common at $1.60/share, immediately exercisable) with related warrants to buy a total of 6.25M common shares. (PR) Comment! [On the Move, Healthcare]
Thursday, May 30, 9:13 AM Premarket gainers: NVE +22%. CLWR +20%. MY +15%. CLSN +13%. HSOL +12%. CPST +10%. EXPR +9%. LXRX +8%. BLDP +8%. VRNG +7%. RSOL +6%. WFR +6%. AMRN +6%. FSLR +6%. ALU +6%. EMC +6%. STP +5%. HIMX +5%. OCZ +5%.
Losers: ABIO -31%. BIG -9%. VNR -5%. BPFH -5%. 1 Comment [On the Move]
Tuesday, April 23, 12:56 PM Midday top 10 gainers: SCON +118%. MEMS +49%. CZR +29%. NFLX +24%. ARL +18%. CPLA +18%. VECO +17%. HSTM +17%. SANM +16%. ILMN +15%.
Midday top 10 losers: CPRX -15%. IIVI -13%. UNTK -13%. ABIO -13%. CASM -10%. EFUT -9%. GASS -9%. TAX -8%. SIFY -7%. USTR -7%. Comment! [On the Move]
Monday, April 22, 9:10 AM Premarket gainers: PWER +56%. ABIO +47%. MPR +40%. SILC +7%. SAND +5%. Comment! [On the Move]
Monday, April 22, 8:43 AM Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic (MDT) on a Phase 2b clinical trial for Gencaro, ABIO's lead developmental drug for the treatment of cardiac rhythm disorders. Comment! [Healthcare, On the Move]
Tuesday, March 26, 12:12 PM Arca Biopharma (ABIO -6.2%) trades down today after the company filed a registration with the SEC to sell, from time to time, up to $20M of its stock and warrants. Comment! [Healthcare, On the Move]
Friday, March 8, 12:44 PM Midday top 10 gainers: AQ +36%. GMXR +35%. MEET +22%. AMBA +22%. III +22%. ABIO +21%. PRGN +20%. BVSN +19%. P +18%. WG +17%.
Midday top 10 losers: SKUL -22%. PGRX -19%. SUTR -16%. TECUA -16%. FREE -15%. ANGO -13%. MXWL -13%. AVG -11%. ARCI -10%. OTIV -8%. Comment! [On the Move]
Tuesday, March 5, 10:50 AM ARCA Biopharma (ABIO +6.7%) trades up after announcing a 6-for-1 reverse split of its common stock, which became effective after the close yesterday, and trading on the NASDAQ on a split adjusted basis as of today. The reverse split reduces ABIO's number of shares issued and outstanding from approximately 19.1M shares to approximately 3.2M shares. Comment! [Healthcare, On the Move]
Wednesday, January 30, 9:29 AM ARCA Biopharma (ABIO) +51.9% premarket after announcing plans for a phase 3 adaptive design clinical trial for its lead developmental drug, Gencaro, in atrial fibrillation. Medtronic (MDT) will be collaborating on the initial, phase 2B portion of the proposed trial. Comment! [Healthcare, On the Move]
Wednesday, December 12, 2012, 1:50 PM Arca Biopharma (ABIO +30%) soars today after announcing that a paper was published in the European Journal of Heart Failure which presented data demonstrating that patients with established atrial fibrillation who received ABIO's Gencaro had improvements in heart failure clinical endpoints. The data also showed that Gencaro made it more likely for patients to achieve ventricular rate control, and that Gencaro improved cardiovascular clinical endpoints for those patients who did achieve rate control. Comment! [Healthcare, On the Move, Global & FX]
Friday, March 26, 2010, 3:27 PM ARCA Biopharma (ABIO +236.6%) shares skyrocket after the company receives a patent protecting its heart-failure treatment methods. (PR) Comment!

ABIO Arca Biopharma, Inc.

ABIO

Arca Biopharma, Inc.